InsidersTradesSigma
Follow the NeuroSense Therapeutics Ltd. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). The latest transaction was disclosed on 17 June 2026 (Acquisition). Among the most active insiders: Ben-Noon Alon. Every trade is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
NeuroSense Therapeutics Ltd. is a biopharmaceutical company focused on developing treatments for neurodegenerative diseases. It is listed on the NASDAQ.